Designing Confidence - the Future of Insight, Integrity, and Impact in Omics+ Bold, unscripted fishbowl exchange with omics leaders across translational research, statistics, systems biology, drug development - and everything in between. Rotate in to join the discussion with:Chiara Guerrera, Scientific Director, INSERMHarris Bell-Temin, Ph.D., Director of Proteomics, Johnson & JohnsonJoey. C Latham, Ph.D., Executive Director Multiomics, PTC TherapeuticsOlga Vitek, Professor and Director, Northeastern University + Keynote: E2E Proteomics: From Ad Hoc to Essential in Drug Discovery. How Johnson & Johnson is transforming drug discovery with end-to-end proteomics — using standardization and automation to enhance analytics and portfolio impact. Harris Bell-Temin, Ph.D., Director of Proteomics, Johnson & Johnson+ The release of Mass Dynamics 3.0 — our most powerful release yet that unlocks productivity, creativity, and deeper team adoption - at scaleEvent details:When: Sunday, 1st June, 2025, 3pm - 6pmWhere: Bearman Gallery, Living Classrooms at Frederick Douglass-Isaac Myers Museum1417 Thames Street, Baltimore (Short 20 min walk from Baltimore Convention Center)Includes: Complimentary Drinks, Appetizers, and be the first to receive our exclusive ASMS gift bag.More Mass Dynamics at ASMS 2025 Learn more about Mass Dynamics and where you can find us throughout the ASMS 2025 Scientific Program here
Mass Dynamics needs the contact information you provide to us to contact you about this challenge. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, please review our Privacy Policy.